Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study

Abstract Background Antiretroviral therapy has prolonged the lives of those with human immunodeficiency virus (HIV), but the effects of chronic infection on their health-related quality of life (HRQoL) remain a concern. Numerous instruments have been developed to measure HRQoL, yet evidence of their...

Full description

Bibliographic Details
Main Authors: Diana Barger, Mojgan Hessamfar, Didier Neau, Marc-Olivier Vareil, Estibaliz Lazaro, Pierre Duffau, Nicolas Rouanes, Olivier Leleux, Fabien Le Marec, Marie Erramouspe, Linda Wittkop, François Dabis, Fabrice Bonnet
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Health and Quality of Life Outcomes
Subjects:
HIV
Online Access:http://link.springer.com/article/10.1186/s12955-020-01451-8
id doaj-155e6bce1c41478291d25c828cc7bb6c
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Diana Barger
Mojgan Hessamfar
Didier Neau
Marc-Olivier Vareil
Estibaliz Lazaro
Pierre Duffau
Nicolas Rouanes
Olivier Leleux
Fabien Le Marec
Marie Erramouspe
Linda Wittkop
François Dabis
Fabrice Bonnet
spellingShingle Diana Barger
Mojgan Hessamfar
Didier Neau
Marc-Olivier Vareil
Estibaliz Lazaro
Pierre Duffau
Nicolas Rouanes
Olivier Leleux
Fabien Le Marec
Marie Erramouspe
Linda Wittkop
François Dabis
Fabrice Bonnet
Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study
Health and Quality of Life Outcomes
HIV
Health-related quality of life
WHOQOL-HIV BREF
author_facet Diana Barger
Mojgan Hessamfar
Didier Neau
Marc-Olivier Vareil
Estibaliz Lazaro
Pierre Duffau
Nicolas Rouanes
Olivier Leleux
Fabien Le Marec
Marie Erramouspe
Linda Wittkop
François Dabis
Fabrice Bonnet
author_sort Diana Barger
title Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study
title_short Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study
title_full Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study
title_fullStr Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study
title_full_unstemmed Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study
title_sort assessing the psychometric properties of the french whoqol-hiv bref within the anrs co3 aquitaine cohort’s qualiv ancillary study
publisher BMC
series Health and Quality of Life Outcomes
issn 1477-7525
publishDate 2020-07-01
description Abstract Background Antiretroviral therapy has prolonged the lives of those with human immunodeficiency virus (HIV), but the effects of chronic infection on their health-related quality of life (HRQoL) remain a concern. Numerous instruments have been developed to measure HRQoL, yet evidence of their cross-cultural equivalence and continued applicability is limited. We adapted the WHOQOL-HIV BREF to French and assessed its psychometric properties in a sample of community-dwelling adults living with HIV who were mostly virally suppressed. Methods We conducted a cross-sectional study within the ANRS CO3 Aquitaine cohort from July 2018 to May 2019. Five hundred eighty-six participants were consecutively enrolled at their HIV-consultations and completed either a web-based (n = 406) or paper self-administered assessment (n = 180). The means and standard deviations for items and domains were computed and the presence of floor and ceiling effects assessed. We evaluated internal consistency by calculating Cronbach’s alpha coefficients per domain. We assessed construct validity by performing a Confirmatory Factor Analysis (CFA). Concurrent, convergent and discriminant validity were assessed with Pearson’s correlations and known-group validity was assessed according to CD4 cell count, viral load, Centers for Disease Control and Prevention clinical categories for HIV, and hospitalization of more than 48 h within 2 years of the most recent consultation using one-way analysis of variance and independent t-tests. Results Five hundred eighty-six PLWH were included in this analysis. Their median age was 55; 73% were male; 85% were of French descent; 99% were on ART and 93% were virally suppressed. We found floor effects for one and ceiling effects for 11 items. Four of the six domains showed good internal consistency (α range: 0.63–0.79). CFA showed that the WHOQOL-HIV BREF’s six-domain structure produced an acceptable fit (SRMR = 0.059; CFI = 0.834; RMSEA = 0.07; 90% CI: 0.06–0.08). It showed good concurrent, convergent and discriminant validity. There was some evidence of known-group validity. The personal beliefs domain had the highest score (15.04 ± 3.35) and the psychological health domain had the lowest (13.70 ± 2.78). Conclusions The French WHOQOL-HIV BREF has acceptable measurement properties. Its broad conceptualisation of HRQoL, going beyond physical and mental health, may be of particular value in our older, treatment-experienced and virally suppressed population. Trial registration ClinicalTrials.gov NCT03296202 (Archived by WebCite at http://www.webcitation.org/6zgOBArps ).
topic HIV
Health-related quality of life
WHOQOL-HIV BREF
url http://link.springer.com/article/10.1186/s12955-020-01451-8
work_keys_str_mv AT dianabarger assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT mojganhessamfar assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT didierneau assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT marcoliviervareil assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT estibalizlazaro assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT pierreduffau assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT nicolasrouanes assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT olivierleleux assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT fabienlemarec assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT marieerramouspe assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT lindawittkop assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT francoisdabis assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
AT fabricebonnet assessingthepsychometricpropertiesofthefrenchwhoqolhivbrefwithintheanrsco3aquitainecohortsqualivancillarystudy
_version_ 1724902061091323904
spelling doaj-155e6bce1c41478291d25c828cc7bb6c2020-11-25T02:14:05ZengBMCHealth and Quality of Life Outcomes1477-75252020-07-0118111410.1186/s12955-020-01451-8Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary studyDiana Barger0Mojgan Hessamfar1Didier Neau2Marc-Olivier Vareil3Estibaliz Lazaro4Pierre Duffau5Nicolas Rouanes6Olivier Leleux7Fabien Le Marec8Marie Erramouspe9Linda Wittkop10François Dabis11Fabrice Bonnet12Univ Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401Univ Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Bordeaux (CHU)Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Bordeaux (CHU)Services de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire de Bordeaux (CHU)Services de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire de Bordeaux (CHU)Centre Hospitalier de de PérigueuxUniv Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401Univ Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401AIDES Nouvelle AquitaineUniv Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401Univ Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401Univ Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401Abstract Background Antiretroviral therapy has prolonged the lives of those with human immunodeficiency virus (HIV), but the effects of chronic infection on their health-related quality of life (HRQoL) remain a concern. Numerous instruments have been developed to measure HRQoL, yet evidence of their cross-cultural equivalence and continued applicability is limited. We adapted the WHOQOL-HIV BREF to French and assessed its psychometric properties in a sample of community-dwelling adults living with HIV who were mostly virally suppressed. Methods We conducted a cross-sectional study within the ANRS CO3 Aquitaine cohort from July 2018 to May 2019. Five hundred eighty-six participants were consecutively enrolled at their HIV-consultations and completed either a web-based (n = 406) or paper self-administered assessment (n = 180). The means and standard deviations for items and domains were computed and the presence of floor and ceiling effects assessed. We evaluated internal consistency by calculating Cronbach’s alpha coefficients per domain. We assessed construct validity by performing a Confirmatory Factor Analysis (CFA). Concurrent, convergent and discriminant validity were assessed with Pearson’s correlations and known-group validity was assessed according to CD4 cell count, viral load, Centers for Disease Control and Prevention clinical categories for HIV, and hospitalization of more than 48 h within 2 years of the most recent consultation using one-way analysis of variance and independent t-tests. Results Five hundred eighty-six PLWH were included in this analysis. Their median age was 55; 73% were male; 85% were of French descent; 99% were on ART and 93% were virally suppressed. We found floor effects for one and ceiling effects for 11 items. Four of the six domains showed good internal consistency (α range: 0.63–0.79). CFA showed that the WHOQOL-HIV BREF’s six-domain structure produced an acceptable fit (SRMR = 0.059; CFI = 0.834; RMSEA = 0.07; 90% CI: 0.06–0.08). It showed good concurrent, convergent and discriminant validity. There was some evidence of known-group validity. The personal beliefs domain had the highest score (15.04 ± 3.35) and the psychological health domain had the lowest (13.70 ± 2.78). Conclusions The French WHOQOL-HIV BREF has acceptable measurement properties. Its broad conceptualisation of HRQoL, going beyond physical and mental health, may be of particular value in our older, treatment-experienced and virally suppressed population. Trial registration ClinicalTrials.gov NCT03296202 (Archived by WebCite at http://www.webcitation.org/6zgOBArps ).http://link.springer.com/article/10.1186/s12955-020-01451-8HIVHealth-related quality of lifeWHOQOL-HIV BREF